Please assess the completion status of the following clinical trial:

Trial Title: Tranexamic Acid in Pediatric Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* children undergoing elective cardiac surgery with cardiopulmonary bypass~Exclusion Criteria:~* neonate born within 1 month~* preoperative inotropes~* preoperative mechanical ventilation~* preexisting coagulation disorder~* reoperation within 48 hours~* significant liver or kidney disease~* known allergy to TXA

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Tranexamic acid (Type: ACTIVE_COMPARATOR): 50 mg/kg of tranexamic acid was given as a bolus at the induction of anesthesia, followed by 15 mg/kg of continuous infusion and another 50 mg/kg into the bypass circuit.
- Placebo (Type: PLACEBO_COMPARATOR): same volume of normal saline was given.

Based on this trial design, predict the completion outcome and termination type (if applicable).